Zerigo Health, a San Diego-based provider of an at-home psoriasis treatment, raised $43 million in Series B funding, per Axios. 7wire Ventures led, and was joined by General Catalyst, Dragoneer, Cigna Ventures, Leverage Health Solutions, Leaps by Bayer and insiders SV Health Investors, H.I.G. Capital and Bluestem Capital.
Zerigo Health Raises $43M in Series B
